NATCO drug gets Canadian approval

Hyderabad, Jan 11: City-based NATCO Pharma Limited today announced that the Canadian Regulatory Agency (TPD Health Canada) had approved its Ondansetron 4 mg and 8 mg tablets.

The approval, accorded to its Canada-based marketing partner IP Generics, will facilitate NATCO to market its products in that country, according to a release here today. The TPD-Health Canada had already approved the Citalopram Hydrobromide 20 mg and 40 mg tablets of NATCO earlier, it added.

UNI